BioSpace News Archive

The PA Clinical Network, Pennsylvania’s only health care provider-led clinically integrated network, announced today that Aetna, a CVS Health company and a leading provider of health insurance and related services, has initiated a value-based contract for Aetna’s Medicare Advantage members being cared for in the Network. Aetna offe

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts on Friday, May 15, 2020 at 10:00 a.m. EDT.

BTB Real Estate Investment Trust (TSX: BTB.UN) (“BTB” or the “REIT”) announced today that due to the COVID-19 pandemic and the governmental decree limiting gatherings, its annual meeting of unitholders (“the Meeting”) to will be held via webinar

HJB, today announces that its partner Mabspace Biosciences has received Investigational New Drug (IND) clearance from both the U.S. Food and Drug Administration (FDA) and China National Medical Products Administration (NMPA), for a humanized Claudin18.2 monoclonal antibody program.

Therap Services, the long-standing leader in offering innovative electronic solutions for organizations supporting people in long term care supports, is happy to offer a plan designed for individuals and families to keep track of their personal information, appointments, medical support needs, daily activities, and more.

AMCP, the professional association leading the way to help patients get the medications they need at a cost they can afford, announced that it received two Hermes Creative Awards for its work to rebrand the organization in 2019.

The U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing.

ICU Medical, Inc. is voluntarily recalling one single lot of Lactated Ringer’s Injection, USP.

Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced that the Company will release its 2020 first quarter financial results on Tuesday, May 12, 2020, after the close of the U.S. financial markets.

CENTOGENE, a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced that it will be providing its fully validated SARS-CoV-2-PCR tests to students from the Carolinum High School, the largest high school in Neustrelitz, Germany.